Skip to main content

ACCP Members Lead Response to CDC on COVID-19 Vaccine Recommendation in Children 6 Months and Older

Published on: Sep 5, 2022

ACCP members led a joint advocacy effort with the Pediatric Pharmacy Association (PPA) in response to the CDC approval of both the Moderna and Pfizer-BioNTech vaccines for children 6 months and older.

Representatives from the ACCP Pediatrics PRN and the PPA Immunizations Committee developed the written comment to the ACIP Notice of Meeting (June 17 and 18) on behalf of their respective organizations. The College thanks these authors for their diligent and timely contributions: Amanda Cavness, Pharm.D., BCPPS; Lea S. Eiland, Pharm.D., FASHP, FPPA, BCPS, BCPPS; Jennifer Girotto, Pharm.D., BCPPS, BCIDP; Tracy M. Hagemann, Pharm.D., FCCP, FPPA; and Kathy Pham, Pharm.D., FPPA, BCPPS.

In the written comment, both ACCP and the PPA encourage the CDC to provide resources that help clinicians engage with parents and caregivers to address their concerns on vaccines. The letter also highlights ACCP members’ clinical experience and expertise in vaccine advocacy and asks for future opportunities to remain engaged in the nation’s efforts to build vaccine confidence for young children.

Read the letter submitted to the CDC in full here.

Related links